Real-world outcomes in metastatic HR+/HER2-, HER2+ and triple negative breast cancer after start of first-line therapy

Future Oncology, Ahead of Print.

Source: Future Oncology - May 16, 2023 Category: Cancer & Oncology Authors: Richard W  DeClue Maxine D Fisher Kyna Gooden Mark S Walker Trong Kim Le Source Type: research